Serge Belanger
Stock Analyst at Needham
(4.61)
# 921
Out of 5,022 analysts
981
Total ratings
45.8%
Success rate
11.3%
Average return
Main Sectors:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Reiterated: Buy | $110 → $70 | $28.64 | +144.41% | 73 | Sep 30, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $112 | $65.60 | +70.73% | 54 | Sep 29, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $18 | $6.96 | +158.62% | 17 | Sep 28, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $78 → $60 | $38.02 | +57.81% | 41 | Sep 18, 2026 | |
| EVMN Evommune | Reiterated: Buy | $28 | $6.92 | +304.62% | 2 | Sep 9, 2026 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Buy | $16 | $8.17 | +95.84% | 59 | Sep 8, 2026 | |
| VRCA Verrica Pharmaceuticals | Reiterated: Hold | n/a | $4.38 | - | 49 | Aug 27, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $15 | $7.19 | +108.62% | 36 | Aug 13, 2026 | |
| OMER Omeros | Reiterated: Hold | n/a | $18.61 | - | 55 | Aug 13, 2026 | |
| MANE Veradermics | Reiterated: Buy | $164 | $116.76 | +40.46% | 3 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.3476 | - | 62 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $11.41 | +162.93% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $25.43 | -21.35% | 45 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $23.20 | +106.90% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $8.73 | +335.28% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $13.91 | +65.35% | 52 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $25.16 | +58.98% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $46 | $22.02 | +108.90% | 168 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.14 | - | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $19.40 | +75.26% | 36 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $33 | $25.21 | +30.93% | 81 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.865 | n/a | 9 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.60 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $1.52 | n/a | 1 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0078 | n/a | 2 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $5 | $0.0885 | n/a | 3 | Aug 19, 2016 |
Liquidia
Sep 30, 2026
Reiterated: Buy
Price Target: $110 → $70
Current: $28.64
Upside: +144.41%
Cytokinetics
Sep 29, 2026
Reiterated: Buy
Price Target: $112
Current: $65.60
Upside: +70.73%
Ocular Therapeutix
Sep 28, 2026
Reiterated: Buy
Price Target: $18
Current: $6.96
Upside: +158.62%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $78 → $60
Current: $38.02
Upside: +57.81%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $28
Current: $6.92
Upside: +304.62%
BioCryst Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $16
Current: $8.17
Upside: +95.84%
Verrica Pharmaceuticals
Aug 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.38
Upside: -
CorMedix
Aug 13, 2026
Reiterated: Buy
Price Target: $15
Current: $7.19
Upside: +108.62%
Omeros
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $18.61
Upside: -
Veradermics
Aug 12, 2026
Reiterated: Buy
Price Target: $164
Current: $116.76
Upside: +40.46%
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3476
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $30
Current: $11.41
Upside: +162.93%
Aug 7, 2026
Reiterated: Hold
Price Target: $20
Current: $25.43
Upside: -21.35%
Aug 7, 2026
Reiterated: Buy
Price Target: $48
Current: $23.20
Upside: +106.90%
Aug 7, 2026
Reiterated: Buy
Price Target: $38
Current: $8.73
Upside: +335.28%
Aug 7, 2026
Reiterated: Buy
Price Target: $23
Current: $13.91
Upside: +65.35%
Aug 6, 2026
Rated: Buy
Price Target: $36 → $40
Current: $25.16
Upside: +58.98%
Aug 6, 2026
Reiterated: Buy
Price Target: $56 → $46
Current: $22.02
Upside: +108.90%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.14
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $34
Current: $19.40
Upside: +75.26%
Aug 5, 2026
Reiterated: Buy
Price Target: $32 → $33
Current: $25.21
Upside: +30.93%
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.865
Upside: n/a
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $1.60
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $22
Current: $1.52
Upside: n/a
Jun 26, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.0078
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $11 → $5
Current: $0.0885
Upside: n/a